Sunny Pharmtech (ROCO:6676) Other Current Receivables: NT$19.8 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6676 Sunny Pharmtech Inc ROCO:6676
58 GF Score
Price NT$12.35
GF Value NT$13.36
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Sunny Pharmtech Other Current Receivables?

Sunny Pharmtech ROCO:6676 +0.41% 58 Other Current Receivables is NT$19.8 Mil as of Dec. 2025. GuruFocus rates ROCO:6676 with a GF Score™ of 58/100 and a GF Value™ of NT$13.36 (Fairly Valued). The stock has 6 warning signs investors should review.

Sunny Pharmtech's Other Current Receivables for the quarter that ended in Dec. 2025 was NT$19.8 Mil.

Sunny Pharmtech's quarterly Other Current Receivables increased from Dec. 2024 (NT$12.46 Mil) to Jun. 2025 (NT$13.25 Mil) and increased from Jun. 2025 (NT$13.25 Mil) to Dec. 2025 (NT$19.81 Mil).

Sunny Pharmtech's annual Other Current Receivables increased from Dec. 2023 (NT$8.29 Mil) to Dec. 2024 (NT$12.46 Mil) and increased from Dec. 2024 (NT$12.46 Mil) to Dec. 2025 (NT$19.81 Mil).

Sunny Pharmtech Other Current Receivables Related Terms

Sunny Pharmtech Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Sunny Pharmtech's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunny Pharmtech Other Current Receivables Chart

Sunny Pharmtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial 14.84 4.15 8.29 12.46 19.81

Sunny Pharmtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.29 11.95 12.46 13.25 19.81
ROCO:6676
58GF Score
Sunny Pharmtech Inc ROCO:6676
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunny Pharmtech Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of NT$19.8 Mil mean?
Sunny Pharmtech (ROCO:6676) has a Other Current Receivables of NT$19.8 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Sunny Pharmtech and its competitors.
Is Sunny Pharmtech's Other Current Receivables too high?
Sunny Pharmtech's current Other Current Receivables is NT$19.8 Mil. Overall, Sunny Pharmtech has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sunny Pharmtech's Other Current Receivables compare to VRTX and REGN?
Sunny Pharmtech's Other Current Receivables of NT$19.8 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Sunny Pharmtech and its competitors. Sunny Pharmtech's current Other Current Receivables is NT$19.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunny Pharmtech stock overvalued right now?
Based on GuruFocus' analysis, Sunny Pharmtech (ROCO:6676) is currently considered Fairly Valued. The stock's GF Value™ is NT$13.36, compared to a current price of NT$12.35 — trading 7.6% below its estimated fair value. The current Other Current Receivables is NT$19.8 Mil. Sunny Pharmtech's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Sunny Pharmtech (ROCO:6676), the current Other Current Receivables is NT$19.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunny Pharmtech (ROCO:6676) Overvalued in 2026?

Based on GuruFocus' analysis, Sunny Pharmtech stock appears to be undervalued. The current stock price of NT$12.35 is trading 7.6% below its estimated GF Value™ of NT$13.36. GuruFocus considers Sunny Pharmtech to be Fairly Valued.

Key valuation signals for ROCO:6676:

  • Other Current Receivables: NT$19.8 Mil
  • GF Value™: NT$13.36 vs. price of NT$12.35 (7.6% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the ROCO:6676 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sunny Pharmtech Business Description

Address No.255,Longyuan 1st Road, Hsinchu Science Park, Longtan District, Taoyuan, TWN, 325002
Sunny Pharmtech Inc is a specialty pharmaceutical company. It is now fully-integrated, doing research, development, and manufacturing on both API and finished-dose products, which includes orals, liquids, semi-solids, and parenterals.
58GF Score

Get the complete analysis for ROCO:6676

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$12.35
Price
NT$13.36
GF Value